InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Nova Tina Susan, Présidente. Insider active across 2 companies, notably Arena Pharmaceuticals INC. Aggregated, 5 disclosures have been logged. The latest transaction was disclosed on 3 March 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations5 total
17,776 shares
Common Stock
SEC:0001628280-22-005918:0·
056,546 shares0
Common Stock
SEC:0001384101-22-000052:0·
€267,45310,695 shares@ €25.00730.0087% mcap100.0% of flow
Common Stock
SEC:0001384101-22-000038:0·
03,067 shares0
Common Stock
SEC:0001628280-21-012279·
03,067 shares0
Common Stock
SEC:0001628280-21-012279:0·
5 of 5 declarations
About Nova Tina Susan
Tina Susan Nova is the President and CLIA U.S. Operations Director at ARENA PHARMACEUTICALS INC and VERACYTE, INC. She oversees the operational and strategic activities of both companies, bringing her expertise in the life sciences field. Her role is essential in ensuring regulatory compliance and innovation in product development. Through her leadership, she contributes to the growth and success of the organizations.
